Lecture abstract:

Turbo cancers are a rapidly escalating threat in the wake of the COVID pandemic, forcing doctors to push the boundaries of traditional oncology treatment. This presentation, with Dr. Kathleen Ruddy, Dr. Paul Marik, and Dr. Nathan Goodyear, introduces groundbreaking adjunctive treatment strategies that are reshaping cancer care. Highlighting the role of repurposed drugs like ivermectin, alongside metabolic therapy and lifestyle modifications, the speakers present a more personalized and less invasive approach to cancer treatment. Join us to discover the future of oncology, where innovation meets practicality.

Dr. Marik, an innovator in the practice of critical care medicine, has had an immeasurable impact on the practice of medicine during his 30-year career. With over 500 peer-reviewed journal articles, 80 book chapters, and four critical care books, Dr. Marik is the second-most published critical care physician in the world. He is quadruple board-certified in Internal Medicine, Critical Care Medicine, Neurocritical Care, and Nutrition Science. He also holds advanced degrees in Pharmacology and Anesthesia.

Dr. Marik is known for developing several revolutionary protocols, notably for treating sepsis with intravenous ascorbic acid. In April 2020, Dr. Marik founded FLCCC with fellow critical care colleagues who recognized the urgent need for effective prevention and treatment therapies for COVID-19.

Since then, Dr. Marik has built on this body of work to develop treatment strategies for other complex conditions, like cancer and Type II diabetes, using lifestyle changes, readily available FDAapproved medications, and nutritional supplements. In August 2023, he published ‘Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer.’ This unbiased, objective, and truly scientific evaluation of alternative interventions for the management of cancer has already had a positive impact on the lives of cancer patients.

Dr. Marik’s medical career began in 1989 in Soweto, South Africa. He moved to the United States in 1992, working at Wayne State University, Detroit Receiving Hospital, and several other facilities in the northeastern U.S. before eventually settling at Eastern Virginia Medical School (EVMS) in 2009. In early 2022, Dr. Marik retired from his position at EVMS to dedicate more time to leading the FLCCC and fighting to protect the doctor-patient relationship.

Dr. Ruddy is an internationally recognized breast cancer expert and the founder and president of Breast Health and Healing, her own private practice in New Jersey. She also founded the Breast Health and Healing Foundation and is the creator of the ongoing Pink Virus Project.

Dr. Ruddy’s commitment to helping women with breast cancer began early in her medical career, when her own mother was diagnosed with the disease. After completing her surgical residency as Chief Resident in 1994, Dr. Ruddy was chosen as the first Fellow on the Breast Service at Memorial Sloan-Kettering Cancer Center. The following year, Cancer Treatment Centers of America recruited her to establish the Breast Service at the Clara Maass Medical Center, where she has since cared for more than 6,000 patients while conducting research and initiating projects that focus on how best to deal with the growing epidemic of breast cancer — by trying to understand its causes, rather than focusing exclusively on its cures, with the goal of preventing the disease.